Beacon Therapeutics
Beacon Therapeutics is a biotechnology firm in the clinical stage focused on preserving and enhancing vision for individuals affected by both uncommon and widespread eye disorders. The organization is leveraging the revolutionary potential of gene therapy to achieve significant results for serious eye conditions. Currently, Beacon's pipeline is aimed at severe retinal diseases that cause blindness, including X-linked retinitis pigmentosa (XLRP) and geographic atrophy.
Domain
beacontx.com
Country
United StatesIndustry
BiotechnologyEmployees
101-250
Last Funding
$75.0M
Founded
2022
Tech Stack (12 technologies)
Frequently Asked Questions
What technologies does Beacon Therapeutics use?+
Beacon Therapeutics uses 12 technologies including WordPress, Complianz, PHP.
What industry is Beacon Therapeutics in?+
Beacon Therapeutics operates in the Biotechnology industry.
Where is Beacon Therapeutics based?+
Beacon Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026